《J Pediatrics,6月14日,Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-06-15
  • Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City

    Author links open overlay panelShubhiKaushikMBBS1∗Scott I.AydinMD12∗Kim R.DerespinaMD3Prerna B.BansalMD2ShannaKowalskyDO4RebeccaTrachtmanMD5Jennifer K.GillenMD1Michelle M.PerezMD3Sara H.SoshnickDO, MS3Edward E.ConwayJr.MD6AsherBercowMD6Howard S.SeidenMD2Robert H.PassMD2Henry M.UshayMD, PhD3GeorgeOfori-AmanfoMD12Shivanand S.MedarMD37

    Show more

    https://doi.org/10.1016/j.jpeds.2020.06.045

    Abstract

    Objective

    To assess clinical characteristics and outcomes of SARS-CoV-2 associated multisystem inflammatory syndrome in children (MIS-C).

    Study design

    Children with MIS-C admitted to pediatric intensive care units (PICU) in New York City between April 23 and May 23, 2020 were included. Demographic and clinical data were collected.

    Results

    Of 33 children with MIS-C, the median age was 10 years; 61% were male; 45% were Hispanic/Latino; 39% were black. Comorbidities were present in 45%. Fever (93%) and vomiting (69%) were the most common presenting symptoms. Depressed left ventricular ejection fraction (LVEF) was found in 63% of patients with median EF of 46.6% (IQR 39.5, 52.8). C-reactive protein, procalcitonin, D-dimer, and pro-B-type natriuretic peptide levels were elevated in all patients. For treatment, intravenous immunoglobulin was used in 18 (54%), corticosteroids in 17 (51%), tocilizumab in 12 (36%), remdesivir in 7 (21%), vasopressors in 17 (51%), mechanical ventilation in 5 (15%), extracorporeal membrane oxygenation (ECMO) in 1 (3%), and intra-aortic balloon pump in 1 (3%). The LVEF normalized in 95% of those with depressed EF. All patients were discharged home with median duration of PICU stay of 4.7 (4, 8) days and hospital stay of 7.8 (6, 10.1) days. One (3%) patient died after withdrawal of care secondary to stroke while on ECMO.

  • 原文来源:https://www.sciencedirect.com/science/article/pii/S0022347620307472
相关报告
  • 《JAMA,6月8日,Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-09
    • Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 Elizabeth Whittaker, MD1,2; Alasdair Bamford, MD3,4; Julia Kenny, MD5,6; et alMyrsini Kaforou, PhD2; Christine E. Jones, MD7; Priyen Shah, MD2; Padmanabhan Ramnarayan, MD1,8; Alain Fraisse, MD9; Owen Miller, MD10,11; Patrick Davies, MD12; Filip Kucera, MD13; Joe Brierley, MD14; Marilyn McDougall, MD6,15; Michael Carter, MD6,15; Adriana Tremoulet, MD16; Chisato Shimizu, MD16; Jethro Herberg, MD1,2; Jane C. Burns, MD16; Hermione Lyall, MD1; Michael Levin, MD2; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia Author Affiliations Article Information JAMA. Published online June 8, 2020. doi:10.1001/jama.2020.10369 Abstract Importance  In communities with high rates of coronavirus disease 2019, reports have emerged of children with an unusual syndrome of fever and inflammation. Objectives  To describe the clinical and laboratory characteristics of hospitalized children who met criteria for the pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PIMS-TS) and compare these characteristics with other pediatric inflammatory disorders. Design, Setting, and Participants  Case series of 58 children from 8 hospitals in England admitted between March 23 and May 16, 2020, with persistent fever and laboratory evidence of inflammation meeting published definitions for PIMS-TS. The final date of follow-up was May 22, 2020. Clinical and laboratory characteristics were abstracted by medical record review, and were compared with clinical characteristics of patients with Kawasaki disease (KD) (n = 1132), KD shock syndrome (n = 45), and toxic shock syndrome (n = 37) who had been admitted to hospitals in Europe and the US from 2002 to 2019.
  • 《6月14日_纽约市儿童多系统炎症综合征(MIS-C)与SARS-CoV-2感染的相关性研究》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-19
    • 信息名称:纽约市儿童多系统炎症综合征(MIS-C)与SARS-CoV-2感染的相关性研究 1.时间:2020年6月14日 2.机构或团队:西奈山伊坎医学院西奈山Kravis儿童医院、阿尔伯特爱因斯坦医学院蒙特菲奥雷儿童医院 3.事件概要: 6月14日,The Journal of Pediatrics发表了题为“Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City”的文章。 本文研究目标是探讨SARS-CoV-2感染相关的儿童多系统炎症综合征(MIS-C)的临床特点及预后。研究对象包括在2020年4月23日至5月23日期间纽约市儿科重症监护室(PICU)收治的MIS-C患儿,收集了其人口统计学和临床资料。 研究结果表明,33名MIS-C儿童中,中位年龄为10岁;61%为男性;45%为西班牙裔/拉丁裔;39%为黑人。共病率为45%。发热(93%)和呕吐(69%)是最常见的症状。63%的患者左室射血分数(LVEF)降低,平均EF为46.6%(IQR 39.5,52.8)。C-反应蛋白、降钙素原、D-二聚体和前B-型钠尿肽水平均升高。在体外膜肺氧合治疗中,静脉注射免疫球蛋白18例(54%)、糖皮质激素17例(51%)、托利珠单抗12例(36%)、瑞德西韦7例(21%)、血管加压素17例(51%)、机械通气5例(15%)、体外膜肺氧合术(ECMO)1例(3%)、主动脉内球囊反搏术1例(3%)。95%的EF降低者LVEF正常。所有患者目前均出院回家,平均PICU住院时间4.7天(4,8),总住院时间7.8(6,10.1)天。一名(3%)患者在ECMO期间因中风而退出治疗后死亡。 文章结论,患有COVID-19感染相关的MIS-C危重儿童的严重程度比之前描述的更严重,但仍需要精心的支持性重症监护。快速、完全的临床和心肌恢复几乎是普遍需要的。 4.附件: 原文链接 https://www.sciencedirect.com/science/article/pii/S0022347620307472